Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 33

Results For "LTI"

3153 News Found

Maxivision appoints Karthikeyan V. as SVP–Operations for Tamil Nadu & Kerala
Hospitals | May 11, 2026

Maxivision appoints Karthikeyan V. as SVP–Operations for Tamil Nadu & Kerala

Healthcare operations veteran with over 23 years of experience to lead key initiatives across South India


Lonza surges on biologics boom
News | May 09, 2026

Lonza surges on biologics boom

Expands manufacturing push & locks in major growth deals


Yashoda Medicity unveils specialised thalassemia care centre in Uttar Pradesh
Hospitals | May 08, 2026

Yashoda Medicity unveils specialised thalassemia care centre in Uttar Pradesh

The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services


Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform
News | May 07, 2026

Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform

LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity


Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion
Digitisation | May 07, 2026

Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion

Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows


Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum
News | May 07, 2026

Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum

The standout story remains Wegovy, particularly its new oral formulation


Eli Lilly unveils $4.5 bn Indiana expansion
News | May 07, 2026

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies


Samsung Bioepis’ Pembrolizumab biosimilar SB27 meets phase 1 PK endpoints
Biopharma | May 06, 2026

Samsung Bioepis’ Pembrolizumab biosimilar SB27 meets phase 1 PK endpoints

The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients


Ajanta Pharma Q4 FY26 revenue surges 21% to Rs. 1,422 Crore; PAT climbs 18%
News | May 06, 2026

Ajanta Pharma Q4 FY26 revenue surges 21% to Rs. 1,422 Crore; PAT climbs 18%

FY26 revenue rises 17% to Rs. 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter